See more : Exelixis, Inc. (EX9.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Cloud DX Inc. (CDXFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cloud DX Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Isracard Ltd. (ISCD.TA) Income Statement Analysis – Financial Results
- Uniinfo Telecom Services Limited (UNIINFO.NS) Income Statement Analysis – Financial Results
- FarGlory Hotel Co.,Ltd (2712.TW) Income Statement Analysis – Financial Results
- Wasu Media Holding Co.,Ltd (000156.SZ) Income Statement Analysis – Financial Results
- Helios Energy Limited (HLEGF) Income Statement Analysis – Financial Results
Cloud DX Inc. (CDXFF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.clouddx.com
About Cloud DX Inc.
Cloud DX Inc. operates as a remote patient monitoring company. It offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including chronic obstructive pulmonary disease and congestive heart failure, as well as patients recovering from surgery and COVID-19 patients outside hospitals. The company's Cloud DX Connected Health Kits includes its Cloud DX Bluetooth pulse oximeter, the Cloud DX wireless weight scale and optionally, a wireless Bluetooth blood pressure monitor, digital thermometer, and digital wireless glucose meter from 3rd party suppliers. It serves academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company also offers VITALITI, a vital sign monitor for measuring electrocardiograph, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Brooklyn, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 1.81M | 1.17M | 782.30K | 1.16M | 1.25M | 247.77K |
Cost of Revenue | 529.21K | 563.11K | 491.29K | 732.60K | 228.17K | 127.76K |
Gross Profit | 1.28M | 602.90K | 291.01K | 431.20K | 1.02M | 120.01K |
Gross Profit Ratio | 70.79% | 51.71% | 37.20% | 37.05% | 81.76% | 48.44% |
Research & Development | 192.99K | 397.93K | 473.88K | 550.52K | 252.57K | 317.86K |
General & Administrative | 6.90M | 9.11M | 9.34M | 5.97M | 842.16K | 1.08M |
Selling & Marketing | 252.73K | 312.08K | 468.63K | 116.35K | 153.70K | 159.75K |
SG&A | 7.15M | 9.43M | 9.80M | 6.08M | 287.20K | 6.44M |
Other Expenses | 1.67M | -18.79K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 9.02M | 9.83M | 9.48M | 5.58M | 287.20K | 7.03M |
Cost & Expenses | 9.55M | 10.39M | 9.97M | 6.31M | 287.20K | 7.16M |
Interest Income | 0.00 | 1.60M | 709.40K | 732.23K | 336.99K | 224.11K |
Interest Expense | 3.37M | 1.60M | 709.40K | 732.23K | 0.00 | 0.00 |
Depreciation & Amortization | 477.96K | 498.77K | 407.95K | 340.14K | 164.51K | 168.72K |
EBITDA | -6.93M | -8.79M | -10.24M | -4.74M | -4.40M | -6.82M |
EBITDA Ratio | -382.42% | -748.52% | -1,122.64% | -412.98% | -22.96% | -2,751.18% |
Operating Income | -7.74M | -9.72M | -10.42M | -6.55M | -287.20K | -6.99M |
Operating Income Ratio | -426.90% | -833.54% | -1,332.04% | -562.81% | -22.96% | -2,819.27% |
Total Other Income/Expenses | -3.04M | -1.17M | -934.58K | 737.73K | -4.68M | -146.18K |
Income Before Tax | -10.78M | -10.89M | -11.36M | -5.81M | -312.20K | -7.13M |
Income Before Tax Ratio | -594.93% | -934.04% | -1,451.51% | -499.42% | -24.95% | -2,878.27% |
Income Tax Expense | -433.91K | -273.89K | -98.22K | 732.31K | -164.51K | 0.00 |
Net Income | -10.35M | -10.62M | -11.26M | -5.81M | -312.20K | -7.13M |
Net Income Ratio | -570.99% | -910.55% | -1,438.95% | -499.42% | -24.95% | -2,878.27% |
EPS | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
EPS Diluted | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
Weighted Avg Shares Out | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
Weighted Avg Shares Out (Dil) | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
Cloud DX sees 1Q revenue climb on new and existing contract growth
Cloud DX gross profit more than doubles in 2022
Cloud DX Reports FY2022 Results
Cloud DX to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
Cloud DX inks new US contract; extends two Canadian agreements
Cloud DX posts 150% year-over-year growth in contract extensions; expands five existing contracts
Cloud DX closes first tranche of private placement of units for aggregate gross proceeds of $2,601,884
Cloud DX signs three-year contract with heart centre for remote patient monitoring program
Cloud DX launches first remote monitoring program for patients with type 2 diabetes
Cloud DX inks eighth contract with Ontario paramedicine program to bring remote patient monitoring to community seniors
Source: https://incomestatements.info
Category: Stock Reports